considering that several synthetic reviews of quaternary carbon
centers in a stereoselective fashion have been carried out in
recent years,13 we decided to undertake an in-depth study into
the behavior of the five-membered cyclic sulfamidate (R)-1. In
this compound, the quaternary carbon center is activated for
nucleophilic displacement, and the reactivity with several sulfur
nucleophiles (S nucleophiles) in the SN2 reaction was explored
(Figure 1).
FIGURE 2. Mercapto amino acids and their R- and â-methylated
derivatives.
Significant â-amino acids such as R-methylisocysteine and
S-phenyl-R-methylisocysteine were selected to prove the ap-
plicability of the methodology presented here, that is, the SN2
reaction of cyclic sulfamidate (R)-1, followed by acid hydrolysis,
for the synthesis of â2,2-amino acids as a result of the
significance that some amino acid analogues have attained in
recent years. For example, a large number of studies have
focused on S-phenyl-L-cysteine as a biological marker of human
exposure to benzene.14 Moreover, amino acids bearing a thiol
group appear to be particularly valuable for the generation of
disulfide bridges and, therefore, are capable of generating
restrictions in the peptide backbone.15 â-Methylcysteine has been
used to synthesize glutathione (GSH) analogues, which have
been designed as potential glyoxalase I inhibitors.16 Several
syntheses of R-methylcysteine17 have been reported, and once
again, GSH analogues incorporating both enantiomers of this
amino acid have recently been synthesized.18 Moreover, the total
synthesis of halipeptin A, a potent anti-inflammatory cyclic
depsipeptide that incorporates an R-methylcysteine derivative
unit, was recently achieved by Ma and co-workers.19
synthesized in enantiomerically pure forms by the ring opening
of (2S,3S)-3-methyl-2-aziridinecarboxylic acid.23 Bearing in
mind the crucial role played by the 3-hydroxyl function of
â-phenylisoserine in taxol, the synthesis of analogues containing
the R-thiol function has also been developed.24
In summary, with regard to the R-amino acid cysteine and
the â-amino acid isocysteine, as well as their R- and â-meth-
ylated series (Figure 2), all compounds or derivatives of them
have been previously synthesized in enantiomerically pure
forms, except for R-methylisocysteine. In an effort to cover this
gap, we report here the enantioselective synthesis of this new
â
2,2-amino acid isocysteine derivative. To the best of our
knowledge, only two racemic syntheses of a â2,2-amino acid
incorporating the isocysteine skeleton have been reported in the
literature and these concerned R-methyl-â-phenylisocysteine25
and N-tosyl-R-methylisocysteine derivatives.26
As mentioned above,10 a very short methodology to obtain
enantiomerically pure (R)-1 was used, and this involved using
the recent method reported by Nicolaou and co-workers5 to
synthesize regio- and stereoselective sulfamidates from chiral
1,2-diols using Burgess’ reagent. The nucleophilic ring opening
of sulfamidate (R)-1 was examined using several S nucleophiles
(Table 1). In our procedure, sulfamidate (R)-1 (1.00 equiv) and
the S nucleophile (1.05 or 1.10 equiv, dependent on the method)
were heated in DMF at 50 °C for 1 h, and the sulfamic acid
intermediate was hydrolyzed in an acid medium. The use of
the corresponding method in each case was dependent on the S
nucleophile and on the lability of the functional groups. Indeed,
with sulfur anion derivatives as S nucleophiles, methods A1 or
A2 (absence of base) were selected, while with thiols as S
nucleophiles, DBU was added as a base to deprotonate the SH
group (methods B1 or B2). On the other hand, methods A1 or
B1 (20% H2SO4) were used to hydrolyze the sulfamic acid
intermediate when functional groups that are resistant to acid
hydrolysis are present in the molecule. By contrast, when the
molecule incorporates functional groups that are sensitive to
acid media, methods A2 or B2 (1 M NaH2PO4) were preferred
(Table 1).
As far as isocysteine and its derivatives are concerned, various
syntheses have been reported in the literature,20 and the
replacement of cysteine with this compound in a specific
peptidic sequence generates potent peptide inhibitors of stromely-
sin.21 Moreover, suitably protected isocysteine-based building
blocks have been used to provide convenient access to isocys-
teinyl peptides.22 â-Methylisocysteine derivatives have been
(10) Avenoza, A.; Busto, J. H.; Corzana, F.; Jime´nez-Ose´s, G.; Peregrina,
J. M. Chem. Commun. 2004, 980-981.
(11) (a) Bower, J. F.; Svenda, J.; Williams, A. J.; Charmant, J. P. H.;
Lawrence, R. M.; Szeto, P.; Gallagher, T. Org. Lett. 2004, 6, 4727-4730.
(b) Williams, A. J.; Chakthong, S.; Gray, D.; Lawrence, R. M.; Gallagher,
T. Org. Lett. 2003, 5, 811-814.
(12) Posakony, J. J.; Tewson, T. J. Synthesis 2002, 859-864.
(13) (a) Martin, S. F. Tetrahedron 1980, 36, 419-460. (b) Fuji, K. Chem.
ReV. 1993, 93, 2037-2066. (c) Corey, E. J.; Guzman-Perez, A. Angew.
Chem., Int. Ed. 1998, 37, 388-401. (d) Denissova, I.; Barriault, L.
Tetrahedron 2003, 59, 10105-10146. (e) Kimura, M.; Yamazaki, T.;
Kitazume, T.; Kubota, T. Org. Lett. 2004, 6, 4651-4654.
(14) Rooseboom, M.; Vermeulen, N. P.; Durgut, F.; Commandeur, J.
N. Chem. Res. Toxicol. 2002, 15, 1610-1618.
(15) Hruby, V. J.; Al-Obeidi, F.; Kazmierski, W. Biochem. J. 1990, 268,
249-262.
(16) (a) Xie, X.; Creighton, D. J. Biochem. Biophys. Res. Commun. 1991,
177, 252-258. (b) Lucente, G.; Luisi, G.; Pinnen, F. Il Farmaco 1998, 53,
721-735.
(17) (a) Parsons, R. L.; Heathcock, C. H. J. Org. Chem. 1994, 59, 4733-
4734. (b) Boyce, R. J.; Mulqueen, G. C.; Pattenden, G. Tetrahedron Lett.
1994, 35, 5705-5708. (c) Groth, U.; Scho¨llkopf, U. Synthesis 1983, 37-
38. (d) Mulqueen, G. C.; Pattenden, G.; Whiting, D. A. Tetrahedron 1993,
49, 5359-5364. (e) Wipf, P.; Venkatraman, S.; Miller, C. P. Tetrahedron
Lett. 1995, 36, 3639-3642. (f) Shao, H.; Zhu, Q.; Goodman, M. J. Org.
Chem. 1995, 60, 790-791.
(18) Leplawy, T., Jr.; Slomczynska, U.; Leplawy, M. T.; Marshall, G.
R. In Pept., Proc. Eur. Symp. 21st 1990; Giralt, E., Andreu, D., Eds.;
ESCOM Sci.: Leiden, The Netherlands, 1991; p 285.
All of the S nucleophiles used were commercially available.
In a previous study10 we observed that the SN2 reaction
progresses satisfactorily when a simple S nucleophile (sodium
methanethiolate) was used to give compound (S)-16 in 93%
yield. To explore the scope of the hindered sulfamidate (R)-1
in the ring-opening with different S nucleophiles, we initially
(21) Fotouhi, N.; Lugo, A.; Visnick, M.; Lusch, L.; Walsky, R.; Coffey,
J. W.; Hanglow, A. C. J. Biol. Chem. 1994, 269, 30227-30231.
(22) Dose, C.; Seitz, O. Org. Biomol. Chem. 2004, 2, 59-65.
(23) Hata, Y.; Watanabe, M. Tetrahedron 1987, 43, 3881-3888.
(24) Lee, S.-H.; Qi, X.; Yoon, J.; Nakamura, K.; Lee, Y.-S. Tetrahedron
2002, 58, 2777-2782.
(25) Stefanovic, G.; Stojiljkovic, A.; Stefanovic, M. Tetrahedron 1962,
18, 413-418.
(26) Burgaud, B. G. M.; Horwell, D. C.; Padova, A.; Pritchard, M. C.
Tetrahedron 1996, 52, 13035-13050.
(19) Yu, S.; Pan, X.; Lin, X.; Ma, D. Angew. Chem., Int. Ed. 2005, 44,
135-138.
(20) (a) Gustavson, L. M.; Srinivasan, A. Synth. Commun. 1991, 21,
221-225. (b) Pires, R.; Burger, K. Tetrahedron Lett. 1996, 37, 8159-
8160.
J. Org. Chem, Vol. 71, No. 4, 2006 1693